Generate a tailored SOP for Dr. Elizabeth Heller. Improve your application with a focused, well-structured draft.
Elizabeth Heller is an Associate Professor in the Department of Systems Pharmacology and Translational Therapeutics at the Perelman School of Medicine, University of Pennsylvania. She obtained her Bachelor of Arts degree in Biology from the University of Pennsylvania in 2002 and completed her PhD in Molecular Biology at Rockefeller University in 2009. Her research focuses on the mechanisms by which epigenome remodeling regulates neuronal gene function and behavior. The Heller Lab employs advanced techniques to directly manipulate histone and DNA modifications of specific genes in vivo, utilizing viral delivery of innovative epigenetic editing tools, including zinc-finger transcription factors and CRISPR/dCas9-fusion proteins. High-throughput sequencing is used to identify genes associated with drug-stress regulation, and the lab explores the causal relevance of individual epigenetic modifications to transcriptional regulation and subsequent behavioral adaptations, particularly in the context of addiction and depression. Heller's research addresses the long-term effects of harmful experiences and aims to uncover new therapeutic interventions targeting epigenetic remodeling in the brain.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.